Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 99.82% is 6556% above its 5-year average of 1.50%, near the high end of its 5-year range (-195.39%–99.92%).
As of the fiscal period ended Tuesday, June 30, 2026. 180.07% above its 12-month average of 35.64%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 99.85%.
GROSS MARGIN
99.82%
GROSS MARGIN AVG TTM
35.64%
GROSS MARGIN AVG 3Y
17.45%
GROSS MARGIN AVG 5Y
1.50%
GROSS MARGIN AVG 10Y
-119.55%
GROSS MARGIN AVG 15Y
-2.61%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+180.07%
CURRENT VS 3Y AVG
+471.94%
CURRENT VS 5Y AVG
+6556.18%
CURRENT VS 10Y AVG
+183.49%
CURRENT VS 15Y AVG
+3926.77%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
46.60%
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
+114.21%
vs the sector median at left
Assembly Biosciences, Inc.
Market Cap
$450.64M
Gross Margin
99.82%
TTM Avg
35.64%
3Y Avg
17.45%
5Y Avg
1.50%
Market Cap
$453.70M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$447.43M
Gross Margin
0.00%
TTM Avg
-62.19%
3Y Avg
-231.05%
5Y Avg
-120.70%
Market Cap
$471.57M
Gross Margin
52.05%
TTM Avg
54.84%
3Y Avg
54.67%
5Y Avg
54.23%
Market Cap
$428.16M
Gross Margin
100.00%
TTM Avg
-208.30%
3Y Avg
-64.13%
5Y Avg
-41.74%
Market Cap
$478.54M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
20.00%
Market Cap
$416.68M
Gross Margin
95.50%
TTM Avg
97.75%
3Y Avg
98.88%
5Y Avg
1.50%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | $450.64M | 99.82% | 35.64% | 17.45% | 1.50% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | 0.00% | -62.19% | -231.05% | -120.70% |
| NRC Health (NRC)vs › | $468.31M | 56.33% | 58.27% | 60.30% | 61.48% |
| Cerus Corporation (CERS)vs › | $471.57M | 52.05% | 54.84% | 54.67% | 54.23% |
| Editas Medicine, Inc. (EDIT)vs › | $428.16M | 100.00% | -208.30% | -64.13% | -41.74% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | 0.00% | 0.00% | 25.00% | 20.00% |
| Arvinas, Inc. (ARVN)vs › | $481.33M | 96.43% | 99.01% | 99.50% | 99.67% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $416.68M | 95.50% | 97.75% | 98.88% | 1.50% |
| Carlsmed, Inc. (CARL)vs › | $415.93M | 76.63% | 74.56% | 73.66% | 73.66% |
Gross Margin
99.8%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 99.85% |
| 2026-03-31 | 99.68% |
| 2025-12-31 | 99.92% |
| 2025-09-30 | -53.74% |
| 2025-06-30 | -67.52% |
| 2025-03-31 | -57.67% |
| 2024-12-31 | -94.10% |
| 2024-09-30 | -97.44% |
| 2024-06-30 | 99.62% |
| 2024-03-31 | 99.45% |
| 2023-12-31 | 98.83% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | -195.39% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | -2602.31% |
| 2020-09-30 | 22.16% |
| 2020-06-30 | 40.76% |
| 2020-03-31 | -464.71% |
| 2019-12-31 | -365.44% |
| 2019-09-30 | -413.73% |
| 2019-06-30 | -507.14% |
| 2019-03-31 | -484.40% |
| 2018-12-31 | -468.93% |
| 2018-09-30 | -345.86% |
| 2018-06-30 | -454.40% |
| 2018-03-31 | -307.88% |
| 2017-12-31 | -219.62% |
| 2017-09-30 | -310.94% |
| 2017-06-30 | -413.92% |
| 2017-03-31 | -1445.03% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
